Copyright Reports & Markets. All rights reserved.

Global In-Vitro Cancer Diagnostics Market Professional Survey Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Industry Overview of In-Vitro Cancer Diagnostics

      • 1.1 Definition of In-Vitro Cancer Diagnostics
      • 1.2 In-Vitro Cancer Diagnostics Segment by Type
        • 1.2.1 Global In-Vitro Cancer Diagnostics Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Instruments
        • 1.2.3 Reagents and Kits
      • 1.3 In-Vitro Cancer Diagnostics Segment by Applications
        • 1.3.1 Global In-Vitro Cancer Diagnostics Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Laboratories
        • 1.3.3 Hospitals
        • 1.3.4 Others
      • 1.4 Global In-Vitro Cancer Diagnostics Overall Market
        • 1.4.1 Global In-Vitro Cancer Diagnostics Revenue (2014-2025)
        • 1.4.2 Global In-Vitro Cancer Diagnostics Production (2014-2025)
        • 1.4.3 North America In-Vitro Cancer Diagnostics Status and Prospect (2014-2025)
        • 1.4.4 Europe In-Vitro Cancer Diagnostics Status and Prospect (2014-2025)
        • 1.4.5 China In-Vitro Cancer Diagnostics Status and Prospect (2014-2025)
        • 1.4.6 Japan In-Vitro Cancer Diagnostics Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia In-Vitro Cancer Diagnostics Status and Prospect (2014-2025)
        • 1.4.8 India In-Vitro Cancer Diagnostics Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of In-Vitro Cancer Diagnostics
      • 2.3 Manufacturing Process Analysis of In-Vitro Cancer Diagnostics
      • 2.4 Industry Chain Structure of In-Vitro Cancer Diagnostics

      3 Development and Manufacturing Plants Analysis of In-Vitro Cancer Diagnostics

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global In-Vitro Cancer Diagnostics Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of In-Vitro Cancer Diagnostics
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 In-Vitro Cancer Diagnostics Production and Capacity Analysis
      • 4.2 In-Vitro Cancer Diagnostics Revenue Analysis
      • 4.3 In-Vitro Cancer Diagnostics Price Analysis
      • 4.4 Market Concentration Degree

      5 In-Vitro Cancer Diagnostics Regional Market Analysis

      • 5.1 In-Vitro Cancer Diagnostics Production by Regions
        • 5.1.1 Global In-Vitro Cancer Diagnostics Production by Regions
        • 5.1.2 Global In-Vitro Cancer Diagnostics Revenue by Regions
      • 5.2 In-Vitro Cancer Diagnostics Consumption by Regions
      • 5.3 North America In-Vitro Cancer Diagnostics Market Analysis
        • 5.3.1 North America In-Vitro Cancer Diagnostics Production
        • 5.3.2 North America In-Vitro Cancer Diagnostics Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America In-Vitro Cancer Diagnostics Import and Export
      • 5.4 Europe In-Vitro Cancer Diagnostics Market Analysis
        • 5.4.1 Europe In-Vitro Cancer Diagnostics Production
        • 5.4.2 Europe In-Vitro Cancer Diagnostics Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe In-Vitro Cancer Diagnostics Import and Export
      • 5.5 China In-Vitro Cancer Diagnostics Market Analysis
        • 5.5.1 China In-Vitro Cancer Diagnostics Production
        • 5.5.2 China In-Vitro Cancer Diagnostics Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China In-Vitro Cancer Diagnostics Import and Export
      • 5.6 Japan In-Vitro Cancer Diagnostics Market Analysis
        • 5.6.1 Japan In-Vitro Cancer Diagnostics Production
        • 5.6.2 Japan In-Vitro Cancer Diagnostics Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan In-Vitro Cancer Diagnostics Import and Export
      • 5.7 Southeast Asia In-Vitro Cancer Diagnostics Market Analysis
        • 5.7.1 Southeast Asia In-Vitro Cancer Diagnostics Production
        • 5.7.2 Southeast Asia In-Vitro Cancer Diagnostics Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia In-Vitro Cancer Diagnostics Import and Export
      • 5.8 India In-Vitro Cancer Diagnostics Market Analysis
        • 5.8.1 India In-Vitro Cancer Diagnostics Production
        • 5.8.2 India In-Vitro Cancer Diagnostics Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India In-Vitro Cancer Diagnostics Import and Export

      6 In-Vitro Cancer Diagnostics Segment Market Analysis (by Type)

      • 6.1 Global In-Vitro Cancer Diagnostics Production by Type
      • 6.2 Global In-Vitro Cancer Diagnostics Revenue by Type
      • 6.3 In-Vitro Cancer Diagnostics Price by Type

      7 In-Vitro Cancer Diagnostics Segment Market Analysis (by Application)

      • 7.1 Global In-Vitro Cancer Diagnostics Consumption by Application
      • 7.2 Global In-Vitro Cancer Diagnostics Consumption Market Share by Application (2014-2019)

      8 In-Vitro Cancer Diagnostics Major Manufacturers Analysis

      • 8.1 MDx Health Quest Diagnostics
        • 8.1.1 MDx Health Quest Diagnostics In-Vitro Cancer Diagnostics Production Sites and Area Served
        • 8.1.2 MDx Health Quest Diagnostics Product Introduction, Application and Specification
        • 8.1.3 MDx Health Quest Diagnostics In-Vitro Cancer Diagnostics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 R-Biopharm AG
        • 8.2.1 R-Biopharm AG In-Vitro Cancer Diagnostics Production Sites and Area Served
        • 8.2.2 R-Biopharm AG Product Introduction, Application and Specification
        • 8.2.3 R-Biopharm AG In-Vitro Cancer Diagnostics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Signature Diagnostics
        • 8.3.1 Signature Diagnostics In-Vitro Cancer Diagnostics Production Sites and Area Served
        • 8.3.2 Signature Diagnostics Product Introduction, Application and Specification
        • 8.3.3 Signature Diagnostics In-Vitro Cancer Diagnostics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Siemens Healthcare
        • 8.4.1 Siemens Healthcare In-Vitro Cancer Diagnostics Production Sites and Area Served
        • 8.4.2 Siemens Healthcare Product Introduction, Application and Specification
        • 8.4.3 Siemens Healthcare In-Vitro Cancer Diagnostics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Randox Laboratories
        • 8.5.1 Randox Laboratories In-Vitro Cancer Diagnostics Production Sites and Area Served
        • 8.5.2 Randox Laboratories Product Introduction, Application and Specification
        • 8.5.3 Randox Laboratories In-Vitro Cancer Diagnostics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Epigenomics AG
        • 8.6.1 Epigenomics AG In-Vitro Cancer Diagnostics Production Sites and Area Served
        • 8.6.2 Epigenomics AG Product Introduction, Application and Specification
        • 8.6.3 Epigenomics AG In-Vitro Cancer Diagnostics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Beckman Coulter
        • 8.7.1 Beckman Coulter In-Vitro Cancer Diagnostics Production Sites and Area Served
        • 8.7.2 Beckman Coulter Product Introduction, Application and Specification
        • 8.7.3 Beckman Coulter In-Vitro Cancer Diagnostics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 Abbott Laboratories
        • 8.8.1 Abbott Laboratories In-Vitro Cancer Diagnostics Production Sites and Area Served
        • 8.8.2 Abbott Laboratories Product Introduction, Application and Specification
        • 8.8.3 Abbott Laboratories In-Vitro Cancer Diagnostics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served

      9 Development Trend of Analysis of In-Vitro Cancer Diagnostics Market

      • 9.1 Global In-Vitro Cancer Diagnostics Market Trend Analysis
        • 9.1.1 Global In-Vitro Cancer Diagnostics Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 In-Vitro Cancer Diagnostics Regional Market Trend
        • 9.2.1 North America In-Vitro Cancer Diagnostics Forecast 2019-2025
        • 9.2.2 Europe In-Vitro Cancer Diagnostics Forecast 2019-2025
        • 9.2.3 China In-Vitro Cancer Diagnostics Forecast 2019-2025
        • 9.2.4 Japan In-Vitro Cancer Diagnostics Forecast 2019-2025
        • 9.2.5 Southeast Asia In-Vitro Cancer Diagnostics Forecast 2019-2025
        • 9.2.6 India In-Vitro Cancer Diagnostics Forecast 2019-2025
      • 9.3 In-Vitro Cancer Diagnostics Market Trend (Product Type)
      • 9.4 In-Vitro Cancer Diagnostics Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 In-Vitro Cancer Diagnostics Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        In-vitro cancer diagnostics is a technique in which the reagents and medical devices are employed to examine specimens such as body fluids, tissues, stool, urine, and blood.

        The global In-Vitro Cancer Diagnostics market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on In-Vitro Cancer Diagnostics volume and value at global level, regional level and company level. From a global perspective, this report represents overall In-Vitro Cancer Diagnostics market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of In-Vitro Cancer Diagnostics in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their In-Vitro Cancer Diagnostics manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        MDx Health Quest Diagnostics
        R-Biopharm AG
        Signature Diagnostics
        Siemens Healthcare
        Randox Laboratories
        Epigenomics AG
        Beckman Coulter
        Abbott Laboratories

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        Instruments
        Reagents and Kits

        Segment by Application
        Laboratories
        Hospitals
        Others

        Buy now